EydisBio is developing a platform of small molecule therapeutics targeting a variety of diseases driven by aberrant inflammatory/autoimmune processes.

EydisBio is developing a platform of small molecule therapeutics targeting a variety of diseases driven by aberrant inflammatory/autoimmune processes.
Coprata is developing a “smart toilet” to conduct in-line specimen sampling and analysis, allowing for better tracking of individual health as well as public health applications through wastewater analysis.
Confluence Water Advisors is commercializing a database built up from rates published by water utilities across the nation, the first of its kind, which can be used by industry to plan a variety of water service projects with an eye toward sustainability and equity.
Centaur Bio is developing technology that enhances the delivery of drugs and other compounds to the brain and other tissues for a variety of indications, including in oncology and central nervous system diseases.
Calidar is developing 4D mammography technologies for in-human use.